Algert Global LLC Apellis Pharmaceuticals, Inc. Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Algert Global LLC holds 82,411 shares of APLS stock, worth $2.85 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

82,411

Previous 123,628 33.34%

Holding current value

$2.85 Million

Previous $4.74 Million 49.87%

% of portfolio

0.06%

Previous 0.16%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$28.84 - $41.15 $1.19 Million - $1.7 Million	-41,217 Reduced 33.34%	82,411 $2.38 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $2.73 Million - $4.28 Million	71,650 Added 137.85%	123,628 $4.74 Million
Q1 2024 May 14, 2024	BUY	$55.39 - $72.47 $612,004 - $800,721	11,049 Added 27.0%	51,978 $3.06 Million
Q4 2023 Feb 14, 2024	SELL	$37.14 - $64.82 $719,587 - $1.26 Million	-19,375 Reduced 32.13%	40,929 $2.45 Million
Q3 2023 Nov 13, 2023	BUY	$23.65 - $89.22 $768,743 - $2.9 Million	32,505 Added 116.93%	60,304 $2.29 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $1.14 Million - $1.39 Million	-14,900 Reduced 34.9%	27,799 $2.53 Million
Q1 2023 May 12, 2023	BUY	$46.59 - $66.96 $441,114 - $633,977	9,468 Added 28.49%	42,699 $2.82 Million
Q3 2022 Nov 15, 2022	BUY	$44.76 - $69.66 $82,671 - $128,662	1,847 Added 5.89%	33,231 $2.27 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $390,013 - $658,474	11,121 Added 54.88%	31,384 $1.42 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $457,292 - $697,931	12,896 Added 175.05%	20,263 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$30.74 - $49.16 $226,461 - $362,161	7,367 New	7,367 $348,000
Q2 2021 Aug 13, 2021	SELL	$40.9 - $64.9 $367,241 - $582,737	-8,979 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$40.8 - $57.39 $955,699 - $1.34 Million	-23,424 Reduced 72.29%	8,979 $385,000
Q4 2020 Feb 12, 2021	SELL	$30.79 - $57.2 $97,665 - $181,438	-3,172 Reduced 8.92%	32,403 $1.85 Million
Q3 2020 Nov 16, 2020	SELL	$25.89 - $33.65 $325,178 - $422,644	-12,560 Reduced 26.09%	35,575 $1.07 Million
Q2 2020 Aug 12, 2020	SELL	$24.8 - $38.49 $43,400 - $67,357	-1,750 Reduced 3.51%	48,135 $1.57 Million
Q1 2020 May 13, 2020	BUY	$17.91 - $44.33 $893,440 - $2.21 Million	49,885 New	49,885 $1.34 Million

Others Institutions Holding APLS

# of Institutions

309

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.79B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Apellis Pharmaceuticals, Inc. Transaction History